Portal de Periódicos da CAPES

Policy recommendations and cost implications for a more sustainable framework for European human biomonitoring surveys

2014; Elsevier BV; Volume: 141; Linguagem: Inglês

10.1016/j.envres.2014.10.012

1096-0953

Anke Joas, Lisbeth E. Knudsen, Marike Kolossa‐Gehring, Ovnair Sepai, Ludwine Casteleyn, Greet Schoeters, J. Angerer, Argelia Castaño, Dominique Aerts, Pierre Biot, Milena Horvat, Louis Bloemen, M. Fátima Reis, Ioana-Rodica Lupsa, Andromachi Katsonouri, Milena Černá, Marika Berglund, Pierre Crettaz, Péter Rudnai, Katarína Halzlová, Maurice Mulcahy, Arno C. Gutleb, Marc Fischer, Georg Becher, Nadine Fréry, Génon K. Jensen, Lisette van Vliet, Holger M. Koch, Elly Den Hond, Ulrike Fiddicke, Marta Esteban, Karen Exley, Gerda Schwedler, Margarete Seiwert, Danuta Ligocka, Philipp Hohenblum, Soterios Α. Kyrtopoulos, Maria Botsivali, Elena DeFelip, Claude Guillou, Fabiano Reniero, Regina Gražulevičienė, Toomas Veidebaum, Thit Aarøe Mørck, Jeanette K.S. Nielsen, Janne Jensen, Teresa C. Rivas, Jinny Sánchez, Gudrun Koppen, Roel Smolders, Szilvia Középesy, Adamos Hadjipanayis, Andrea Krsková, Russell Mannion, M. Jakubowski, J. Aleksandra Fucic, José Pereira Miguel, Anca Elena Gurzău, Michal Jajcaj, Darja Mazej, Janja Snoj Tratnik, Andrea Lehmann, Kristin Larsson, Birgit Dumez, Reinhard Joas,

Air Quality and Health Impacts

The potential of Human Biomonitoring (HBM) in exposure characterisation and risk assessment is well established in the scientific HBM community and regulatory arena by many publications. The European Environment and Health Strategy as well as the Environment and Health Action Plan 2004-2010 of the European Commission recognised the value of HBM and the relevance and importance of coordination of HBM programmes in Europe. Based on existing and planned HBM projects and programmes of work and capabilities in Europe the Seventh Framework Programme (FP 7) funded COPHES (COnsortium to Perform Human Biomonitoring on a European Scale) to advance and improve comparability of HBM data across Europe. The pilot study protocol was tested in 17 European countries in the DEMOCOPHES feasibility study (DEMOnstration of a study to COordinate and Perform Human biomonitoring on a European Scale) cofunded (50%) under the LIFE+ programme of the European Commission. The potential of HBM in supporting and evaluating policy making (including e.g. REACH) and in awareness raising on environmental health, should significantly advance the process towards a fully operational, continuous, sustainable and scientifically based EU HBM programme. From a number of stakeholder activities during the past 10 years and the national engagement, a framework for sustainable HBM structure in Europe is recommended involving national institutions within environment, health and food as well as European institutions such as ECHA, EEA, and EFSA. An economic frame with shared cost implications for national and European institutions is suggested benefitting from the capacity building set up by COPHES/DEMOCOPHES.